The World Turns to China for Vaccines After India, U.S. Stumble
India’s raging virus outbreak has stifled its ability to deliver on supply deals
India’s raging virus outbreak has stifled its ability to deliver on supply deals
The vast majority of the post-vaccination Covid-19 cases and fatalities were among vulnerable, elderly people, the researchers said
The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced on March 11
Now the worry for Nepal health officials is that its vaccines are accumulating faster than it is able to utilise them.
The global vaccine rollout has exposed glaring inequalities in access to this life-saving tool. Only one of the 47 countries that have started vaccination to date is a low-income country.
The huge vaccine reservoir means that COVAX, a 190-country international initiative that seeks to ensure all countries have equal access to coronavirus vaccines, can plan to start delivering the shots in the first quarter of 2021.
U.S. West Texas Intermediate (WTI) crude futures rose 23 cents, or 0.5%, to $45.75 a barrel at 0200 GMT, while Brent crude futures climbed 21 cents, or 0.4%, to $49.07 a barrel. Prices were little changed overnight
The British regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), says the jab, which claims to offer up to 95 per cent protection against COVID-19 illness, is safe for roll out.
By IAR Desk India will receive 100M coronavirus vaccine doses from Russia.India is reportedly one
The Russian government has reached out to India seeking a collaboration for manufacturing its COVID-19 vaccine ‘Sputnik V’ and conducting its phase 3 clinical trial here,